Fuxiang Pharmaceutical: Maintains a cautiously optimistic attitude towards the price trend of VC products in the second quarter. The company's VC product capacity will increase to 10,000 tons/year.

2026-03-04 16:16:06

Gelonghui March 2 | Fuxiang Pharmaceutical (300497.SZ) announced in an investor relations activity record that the company’s VC product capacity plan will be increased to 10,000 tons/year through technological upgrades, expected to be completed by the second quarter of 2026. The company is cautiously optimistic about the price trend of VC products in the second quarter and will continue to control costs to enhance competitiveness. Additionally, the company plans to advance a microbial protein project in 2026, which, once completed, will have an annual production capacity of 20,000 tons of microbial protein and 50,000 tons of amino acid water-soluble fertilizer products.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.